Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-
2 infection and is associated with both acute and chronic disorders affecting the nervous …
2 infection and is associated with both acute and chronic disorders affecting the nervous …
Characteristics of viral pneumonia in the COVID-19 era: an update
Influenza virus, rhinovirus, and adenovirus frequently cause viral pneumonia, an important
cause of morbidity and mortality especially in the extreme ages of life. During the last two …
cause of morbidity and mortality especially in the extreme ages of life. During the last two …
Practical recommendations for optimal thromboprophylaxis in patients with COVID-19: a consensus statement based on available clinical trials
KG Kyriakoulis, E Dimakakos, IG Kyriakoulis… - Journal of clinical …, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) has been shown to be strongly associated with
increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in …
increased risk for venous thromboembolism events (VTE) mainly in the inpatient but also in …
Flavonoids as a therapeutical option for the treatment of thrombotic complications associated with COVID‐19
JP Quintal Martinez… - Phytotherapy …, 2023 - Wiley Online Library
The SARS‐CoV‐2 outbreak has been one of the largest public health crises globally, while
thrombotic complications have emerged as an important factor contributing to mortality …
thrombotic complications have emerged as an important factor contributing to mortality …
The effect of anakinra in hospitalized patients with COVID-19: an updated systematic review and meta-analysis
The role of immunomodulatory agents in the treatment of hospitalized patients with COVID-
19 has been of increasing interest. Anakinra, an interleukin-1 inhibitor, has been shown to …
19 has been of increasing interest. Anakinra, an interleukin-1 inhibitor, has been shown to …
High versus standard intensity of thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis
Thromboprophylaxis in hospitalized patients with COVID-19 has been associated with a
survival benefit and is strongly recommended. However, the optimal dose of …
survival benefit and is strongly recommended. However, the optimal dose of …
[HTML][HTML] Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing
A Kollias, G Poulakou, E Dimakakos… - Thrombosis …, 2021 - ncbi.nlm.nih.gov
Moll et al. recently published a retrospective analysis of COVID-19 patients admitted to
intensive care unit (ICU) from a single tertiarycare academic hospital showing that there was …
intensive care unit (ICU) from a single tertiarycare academic hospital showing that there was …
Epidemiology, pathogenesis, and management of Coronavirus disease 2019-associated stroke
L Liu, C Zhou, H Jiang, H Wei, Y Zhou, C Zhou, X Ji - Frontiers of Medicine, 2023 - Springer
Abstract The Coronavirus disease 2019 (COVID-19) epidemic has triggered a huge impact
on healthcare, socioeconomics, and other aspects of the world over the past three years. An …
on healthcare, socioeconomics, and other aspects of the world over the past three years. An …
COVID-19 in thrombosis research: An editorial perspective
The coronavirus disease (COVID-19) pandemic has impacted every aspect of our lives.
Scientific research has not been spared. In the face of this global health emergency …
Scientific research has not been spared. In the face of this global health emergency …